THERESA CHEVALIER: Open Payments
NPI 1356528939 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 10 payments from 9 companies in 2025. Trend: 2023 $767 · 2024 $148 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $184 |
| Astellas Pharma US Inc | 1 | $125 |
| Octapharma USA, Inc. | 1 | $33 |
| Hologic Sales and Service, LLC | 1 | $26 |
| Exeltis, USA Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
Products named: QULIPTA, Veozah, UBRELVY, FIBRYGA, FETAL FIBRONECTIN ENZYME IMMUNOASSAY, SLYND, Cologuard Collection Kit, PURAPLY WOUND MATRIX.
Industry payments across NV — which companies pay providers there.
